Teva Canada head elected chair of CGPA
This article was originally published in SRA
Barry Fishman, the president and chief executive of Teva Canada, has been elected chair of the Canadian Generic Pharmaceutical Association. Mr Fishman, who will serve a two-year term, replaces Pierre Fréchette of Sandoz Canada. In addition, Mario Deschamps, the president and chief operating officer of Pharmascience, has been named vice chair.